Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
697 participants
OBSERVATIONAL
2014-11-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HES
Balanced HES 130/0.4 used as and pump prime and for intraoperative fluid therapy.
HES
2500 mL of balanced HES 130/0.4
Crystalloid
Balanced Crystalloid used as a pump prime and for intraoperative fluid therapy.
Crystalloid
2500 mL of balanced crystalloid.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HES
2500 mL of balanced HES 130/0.4
Crystalloid
2500 mL of balanced crystalloid.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having on pump cardiac surgery at CHU of Liège between April 2013 and June 2014
Exclusion Criteria
* Use of Blood or Albumin in the cardiopulmonary bypass priming solution
* Preoperative dialysis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean François Brichant
Professor of Anesthesia and Intensive Care Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANES2015002
Identifier Type: -
Identifier Source: org_study_id